Icoreconnect Common Stock Stock Price To Sales
ICCT Stock | USD 0.17 0.01 5.56% |
iCoreConnect Common stock fundamentals help investors to digest information that contributes to ICoreConnect Common's financial success or failures. It also enables traders to predict the movement of ICoreConnect Stock. The fundamental analysis module provides a way to measure ICoreConnect Common's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ICoreConnect Common stock.
Last Reported | Projected for Next Year | ||
Price To Sales Ratio | 1.12 | 1.06 |
ICoreConnect | Price To Sales |
iCoreConnect Common stock Company Price To Sales Analysis
ICoreConnect Common's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current ICoreConnect Common Price To Sales | 0.41 X |
Most of ICoreConnect Common's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, iCoreConnect Common stock is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
ICoreConnect Price To Sales Driver Correlations
Understanding the fundamental principles of building solid financial models for ICoreConnect Common is extremely important. It helps to project a fair market value of ICoreConnect Stock properly, considering its historical fundamentals such as Price To Sales. Since ICoreConnect Common's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ICoreConnect Common's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ICoreConnect Common's interrelated accounts and indicators.
Click cells to compare fundamentals
ICoreConnect Price To Sales Historical Pattern
Today, most investors in ICoreConnect Common Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ICoreConnect Common's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of ICoreConnect Common price to sales as a starting point in their analysis.
ICoreConnect Common Price To Sales |
Timeline |
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition |
ICoreConnect Price To Sales Ratio
Price To Sales Ratio |
|
Based on the latest financial disclosure, iCoreConnect Common stock has a Price To Sales of 0.4051 times. This is 98.11% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is 96.45% higher than that of the company.
ICoreConnect Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ICoreConnect Common's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ICoreConnect Common could also be used in its relative valuation, which is a method of valuing ICoreConnect Common by comparing valuation metrics of similar companies.ICoreConnect Common is currently under evaluation in price to sales category among its peers.
ICoreConnect Common Current Valuation Drivers
We derive many important indicators used in calculating different scores of ICoreConnect Common from analyzing ICoreConnect Common's financial statements. These drivers represent accounts that assess ICoreConnect Common's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of ICoreConnect Common's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 52.7M | 7.6M | 16.2M | 15.3M | 9.1M | 8.7M | |
Enterprise Value | 53.2M | 9.2M | 20.1M | 21.9M | 15.8M | 15.0M |
ICoreConnect Fundamentals
Return On Equity | -10.42 | ||||
Return On Asset | -0.66 | ||||
Profit Margin | (2.61) % | ||||
Operating Margin | (0.88) % | ||||
Current Valuation | 15.93 M | ||||
Shares Outstanding | 24.32 M | ||||
Shares Owned By Insiders | 33.45 % | ||||
Shares Owned By Institutions | 9.10 % | ||||
Number Of Shares Shorted | 202.98 K | ||||
Price To Book | 8.91 X | ||||
Price To Sales | 0.41 X | ||||
Revenue | 8.15 M | ||||
Gross Profit | 3.38 M | ||||
EBITDA | (11.88 M) | ||||
Net Income | (15.55 M) | ||||
Cash And Equivalents | 164.26 K | ||||
Total Debt | 7.88 M | ||||
Current Ratio | 0.35 X | ||||
Book Value Per Share | 0.44 X | ||||
Cash Flow From Operations | (8.82 M) | ||||
Short Ratio | 0.02 X | ||||
Earnings Per Share | (3.16) X | ||||
Target Price | 0.5 | ||||
Number Of Employees | 67 | ||||
Beta | 0.68 | ||||
Market Capitalization | 4.16 M | ||||
Total Asset | 15.69 M | ||||
Retained Earnings | (115.04 M) | ||||
Working Capital | (5.37 M) | ||||
Net Asset | 15.69 M |
About ICoreConnect Common Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze iCoreConnect Common stock's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ICoreConnect Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of iCoreConnect Common stock based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ICoreConnect Stock Analysis
When running ICoreConnect Common's price analysis, check to measure ICoreConnect Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICoreConnect Common is operating at the current time. Most of ICoreConnect Common's value examination focuses on studying past and present price action to predict the probability of ICoreConnect Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICoreConnect Common's price. Additionally, you may evaluate how the addition of ICoreConnect Common to your portfolios can decrease your overall portfolio volatility.